Overview

Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat. 

Last reviewed: 13 November 2019

Diagnostics guidance 38 has been migrated to HealthTech guidance 531. The recommendations and accompanying content remain unchanged.

This guidance replaces the NICE medtech innovation briefing on point-of-care diagnostic testing in primary care for strep A infection in sore throat (MIB145).

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE HealthTech guidance